Daniel Bachovchin

Sloan-Kettering Inst Can Research

$8,826,435

Attributed

$8,826,435

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.7M · FY2018–25

$2M$1.5M$1M$500K$0

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$8,826,435 · 3

By mechanism

R01$8,826,435 · 3

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Ottavio Arancio$29,644,569
Yueming Li$15,364,718
Jason S Lewis$26,024,327
Michelle S Bradbury$7,087,200
Raymond J Muller$2,385,467

Others in their field

Other Emerging Leaders on “Cell Death”

Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Barbara Burtness · Yale University$11,235,253
James Dale Berry · Brigham And Women'S Hospital$11,004,714
William H. Peranteau · Children'S Hosp Of Philadelphia$10,264,302
Adam David Hoppe · South Dakota State University$9,046,059
Amit Singal · Ut Southwestern Medical Center$8,676,653

Research focus

Cell DeathResearch Project GrantsMalignant NeoplasmsLyticProteinsLaboratoriesMolecularN-TerminalImmune SystemCasp1 GenePublic HealthInflammatoryInnate Immune SystemAutoimmune DiseasesInhibitorNatural ImmunityCellsPathogenInflammasomeMediatingSignal TransductionMultiprotein ComplexesDipeptidesPeptides